RecruitingNCT05853419
Change History and Adopt a Robotic SolutioN for anGioplasty procedurE
Sponsor
Robocath
Enrollment
500 participants
Start Date
Jun 20, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The main objective of the CHANGE registry is the evaluation of the real-world performance and safety profile of the R-One System in PCI.
Eligibility
Min Age: 18 YearsMax Age: 120 Years
Inclusion Criteria4
- \. Age ≥ 18 years;
- Subjects with coronary artery disease with clinical indication for PCI;
- Subject deemed appropriate for robotic-assisted PCI; and
- The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
Exclusion Criteria5
- Failure/inability/unwillingness to provide informed consent, unless the ethic committee has waived informed consent; or
- The Investigator determines that the subject or the coronary anatomy is not suitable for robotic-assisted PCI.
- STEMI
- Cardiogenic shock
- Subjects will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICERobotic-assisted PCI
Robotic-assisted PCI will be performed according to the routine hospital practices, current scientific guidelines and following Instructions for Use (IFU) provided by the manufacturer
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05853419
Related Trials
Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
NCT067368998 locations
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT016215941 location
Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)
NCT062732934 locations
Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial
NCT0559906149 locations
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
NCT065355681 location